This site is intended for health professionals only

Read the latest issue online
Overwhelmed and undervalued

MSD has been discovering, developing and delivering vaccines to help prevent disease around the world for over 100 years, with a strong heritage in childhood immunisations. MSD is committed to support the provision of valuable resources and education for healthcare professionals and for the public. On this page you will find information and resources designed to help you respond to questions around the treatment and prevention of chickenpox.


Giving the right advice to parents helps individuals to deal with chickenpox appropriately, but it’s possible to help protect the wider community at the same time.

By asking a few simple questions in every consultation, you can reinforce to parents the importance of preventing spread of the disease, while also identifying anyone else who may be at risk.



When a parent comes to you for advice on chickenpox, make sure you ask the following questions:

Does the child normally attend school, nursery or other childcare?

If yes, click here

Highlight the importance of keeping them at home until the last blister has scabbed over (usually around 5 days after the spots appear).

Does the child come into contact with the elderly or immunocompromised people?

If yes, click here

Advise the parent to keep the child away from these groups of people until the disease is no longer contagious.

Does the child come into contact with pregnant women or newborns?

If yes, click here

Advise the parent to keep the child away from these people until the disease is not contagious.

Does the child have any siblings who are yet to catch chickenpox?

If yes, click here

Advise the parent on early symptoms to look out for. You may also want to inform them that chickenpox vaccinations are available in the UK.

Download the checklist Prescribing information

Vaccination within 3 days of exposure may prevent a clinically apparent infection or modify the course of the infection.


Job code: GB-VVX-00258 Date of prep: Jan 2022